Serum Levels of Club-Cell Protein 16 (CC-16), Surfactant Protein D (SPD), soluble Receptor of Glycation End-products (sRAGE), Fibrinogen and C-Reactive Protein (CRP) and FEV1 Decline, Exacerbations and Mortality in SUMMIT

B. Celli Croquer (Boston, United States of America)

Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes

Session: Towards personalised medicine in COPD: biological and clinical phenotypes
Session type: Oral Presentation
Number: 511

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Celli Croquer (Boston, United States of America). Serum Levels of Club-Cell Protein 16 (CC-16), Surfactant Protein D (SPD), soluble Receptor of Glycation End-products (sRAGE), Fibrinogen and C-Reactive Protein (CRP) and FEV1 Decline, Exacerbations and Mortality in SUMMIT. 511

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Concentration of C-reactive protein (CRP) in elderly asthmatics Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014
Kinetics of serum adiponectin and HMWA (High Molecular Weight Adiponectin), and mortality in ICU patients with sepsis Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017
Effect of Continuous Positive Airway Pressure (CPAP) on High-Sensitivity C-Reactive Protein levels (hs-CRP) in Patients with Obstructive Sleep Apnea (OSA) Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017
Pattern of phospholipids and Surfactant Protein A in Particles in Exhaled Air (PExA) Source: International Congress 2017 – Techniques in biomarker selection Year: 2017
Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Evaluation of Serum Chitotriozidase Activity and C - reactive protein and Albumin Ratio in Cystic Fibrosis and Bronchopulmonary Dysplasia Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020
Sputum Pregnancy Zone Protein (PZP) - a potential biomarker of bronchiectasis severity Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections Year: 2017
C Reactive Protein (CRP), procalcitonin (PCT) and proadrenomedullin (Pro-ADM), as markers to discriminate bacterial, viral and mixed community acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Association of the Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 Genetic Polymorphisms with Non-small Cell Lung Cancer in Taiwan Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017
Surfactant Protein A in Particles in Exhaled Air and serum Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Surfactant protein D (SPD) and C-reactive protein (CRP) in patient with low respiratory tract infections (LRTI) Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013
Macrophage migration inhibitory factor (MIF), a biomarker in COPD? Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014
Acute phase protein alpha1-antitrypsin - A novel regulator of angiopoietin-like protein 4 transcription and secretion in human cells Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017
LSC - 2017 - Proteasomal Activator 200 (PA200) Regulates Cellular Proliferation: A Putative Role For IPF And Lung Cancer Pathogenesis Source: International Congress 2017 – New insights into pathogenesis of lung disease Year: 2017
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) as a possible biomarker for lung cancer and/or COPD Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014
Routine serum protein electrophoresis and detection of alpha₁-antitrypsin deficiency Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013